1 on, apoptosis, cavitation, and inhibition of syringomyelia.

2 enting with nonsyndromic CMI with or without syringomyelia.

3 myelodysplastic lesions (19 filar lipoma, 14 syringomyelia, 10 intradural lipoma, eight dermal sinus,

4 us (NPH), Chiari type I malformations (CMI), syringomyelia, and after neurosurgical procedures.

5                    We enrolled 156 mild CM-I-syringomyelia cases (Japanese Orthopaedic Association (J

6  space, which are pronounced even further if syringomyelia coexists.

7 ord grafts into patients with post-traumatic syringomyelia demonstrating their feasibility and safety

8 e patients with Chiari I malformation (CM-I)-syringomyelia is uncertain.

9                             Patients without syringomyelia or Chiari malformation identified from the

10 ent optic neuritis, cervical myelopathy from syringomyelia, paraparesis, amenorrhea-galactorrhea, and

11 mes, we examined conservatively managed CM-I-syringomyelia patients' long-term clinical and radiologi

12 as a consequence of brainstem compression or syringomyelia (SM).

13 urological diseases ( eg, spinal dysraphism, syringomyelia, tethered cord syndromes) can give rise to

14 hat the natural course of myelopathy in CM-I-syringomyelia varies according to the OASHS status, Babi

15               Spontaneous resolution of CM-I-syringomyelia was more frequent with cervical syringes (

16 clinic to identify patients with IS-that is, syringomyelia without evidence of Chiari malformation, t